U3O8 Corp.

0.055

Canada & Ontario Toronto

401 Bay Street, Suite 2702

+1 416 868-1491

www.u3o8corp.com

Looking to explore investment opportunities with UWE?

Contact UWE >

Looking to explore investment opportunities with UWE?

Contact UWE >

Is this your business?
Customize your listing.

CLAIM THIS LISTING

Is this your business?
Customize your listing.

Company Press Releases

U3O8 Corp. To Resume Trading

TORONTO, April 27, 2020 (GLOBE NEWSWIRE) -- U3O8 Corp. (NEX: UWE.H), (“U3O8” or the “Company”) reports that, further to the press release dated March 30, 2020, announcing that the Company would not be proceeding with the reverse takeover described in its March 2, 2020 press release, the Company’s submission to TSX Venture Exchange for the lifting of the halt on trading of the Company’s shares, has been accepted. Subject to final regulatory approval, trading of the Company’s common shares will resume on the NEX on opening of the market...

U3O8 Corp. Announces the Termination of the Binding Letter of Intent with Diagnostic Lab Corporation, Inc. and Postpones Reporting of Fourth Quarter and 2019 Full-Year Reporting Due to Delays Caused by COVID-19 Pandemic

TORONTO, March 30, 2020 (GLOBE NEWSWIRE) -- U3O8 Corp. (NEX: UWE.H), (OTCQB: UWEFF) (“U3O8” or the “Company”) announces that, further to the press release dated March 2, 2020, the letter of intent (“LOI”) between the Company and Diagnostic Lab Corporation, Inc. to negotiate and complete a proposed reactivation transaction, has been terminated in accordance with the provisions of the LOI, and the transaction contemplated therein will not proceed. The Company will continue to evaluate other acquisition opportunities with a view to completi...

U3O8 Corp. Announces Proposed Reverse Takeover Transaction with Diagnostic Lab Corporation, Inc.

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, March 03, 2020 (GLOBE NEWSWIRE) -- U3O8 Corp. (NEX: UWE.H), (OTCQB: UWEFF) (“U3O8” or the “Company”) announces that it has entered into a binding Letter of Intent (“LOI”) dated March 2, 2020 with Diagnostic Lab Corporation, Inc. (“DLC”) whereby the business and assets of U3O8 Corp. and DLC will be combined by way of a share exchange between U3O8 Corp. and shareholders of DLC, constituting a “reverse-takeover”...

See All >

Company News

See All >